Stay updated on Cagrilintide & Semaglutide in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Cagrilintide & Semaglutide in Type 2 Diabetes Clinical Trial page.

Latest updates to the Cagrilintide & Semaglutide in Type 2 Diabetes Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded a new Revision: v3.4.2 to the history and removed the funding-lapse notice; the history now reflects the latest release and associated notices. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check21 days agoChange DetectedAdded a government funding notice banner at the top and updated the site version from v3.4.0 to v3.4.1, removing the previous v3.4.0 note.SummaryDifference0.7%

- Check28 days agoChange DetectedThe Record History page now shows color-coded changes (green for additions, red for deletions), includes a glossary display option, and the footer reflects Revision: v3.4.0.SummaryDifference0.9%

- Check42 days agoChange DetectedA new revision entry (v3.3.4) was added to the Record History, and a prior revision (v3.3.3) was removed, an administrative update to the site's version history; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check56 days agoChange DetectedNew contacts/locations and study status entries were added to the study record history (version 14, dated 2025-12-23; also noted on 2025-12-05). The 2025-10-24 version was removed.SummaryDifference0.5%

- Check63 days agoChange DetectedAdded Revision: v3.3.3 to the history. Removed the HHS Vulnerability Disclosure and Revision: v3.3.2 from the page.SummaryDifference0.2%

Stay in the know with updates to Cagrilintide & Semaglutide in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cagrilintide & Semaglutide in Type 2 Diabetes Clinical Trial page.